Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- Countryside Properties hoping for GBP450 million through restructure
7 Jul 2021 - Countryside Properties to focus on Partnerships business
7 Jul 2021 - Tuesday broker round-up
29 Jun 2021 - LONDON MARKET MIDDAY: Stocks lose steam on variant fear; US banks rise
29 Jun 2021 - LONDON MARKET OPEN: Housebuilders rise as UK house prices jump
29 Jun 2021 - TOP NEWS: Barratt poaches Countryside's Scott for finance chief role
29 Jun 2021 - LONDON MARKET PRE-OPEN: UDG agrees increased GBP2.76 billion takeover
29 Jun 2021 - Barratt hires Countryside's Mike Scott as CFO
29 Jun 2021
Related News
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
CSP.L News
Countryside Properties hoping for GBP450 million through restructure
Countryside Properties hoping for GBP450 million through restructure
Countryside Properties to focus on Partnerships business
(Sharecast News) - Countryside Properties said on Wednesday that following a strategic review, it will now focus all of its resources on the Partnersh...
Tuesday broker round-up
(Sharecast News) - South32: Deutsche Bank downgrades to hold with a target price of 180p.
LONDON MARKET MIDDAY: Stocks lose steam on variant fear; US banks rise
LONDON MARKET MIDDAY: Stocks lose steam on variant fear; US banks rise
LONDON MARKET OPEN: Housebuilders rise as UK house prices jump
LONDON MARKET OPEN: Housebuilders rise as UK house prices jump
TOP NEWS: Barratt poaches Countryside's Scott for finance chief role
TOP NEWS: Barratt poaches Countryside's Scott for finance chief role
LONDON MARKET PRE-OPEN: UDG agrees increased GBP2.76 billion takeover
LONDON MARKET PRE-OPEN: UDG agrees increased GBP2.76 billion takeover
Barratt hires Countryside's Mike Scott as CFO
(Sharecast News) - Barratt Developments has hired Mike Scott from Countryside Properties as its next chief financial officer.
Follow the stocks
